Featured Research

from universities, journals, and other organizations

Resistance to visceral Leishmaniasis: New mechanisms involved

Date:
May 16, 2013
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
Researchers have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 and mannose receptors participate in the protection against the parasite responsible for this infection, by triggering an inflammatory response, while the DC-SIGN receptor facilitates the penetration of the pathogen and its proliferation in macrophages.

Researchers from CNRS, Université Toulouse III -- Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 and mannose receptors participate in the protection against the parasite responsible for this infection, by triggering an inflammatory response, while the DC-SIGN receptor facilitates the penetration of the pathogen and its proliferation in macrophages[1]. This work, conducted on both mice and humans and published on 16 May 2013 in the journal Immunity, opens new perspectives for the prevention and treatment of this disease.

Leishmaniasis is one of the most serious fatal parasitic infections in the world: 1.5 to 2 million infected individuals are recorded every year, of which 500,000 involve cases of visceral leishmaniasis. This chronic disease is a public health problem in Latin America, Asia, Africa, and more recently, southern Europe.

Leishmania, the parasite responsible for the infection, colonizes the macrophages where it proliferates. Dectin-1, mannose and DC-SIGN are three receptors of the C-type lectin family, present on the surface of macrophages. Depending on their state of differentiation, they can either contribute to eliminating the parasite or instead facilitate its proliferation by hijacking the defence mechanisms of the macrophage to the parasite's advantage and thus bring about infection. These cells therefore represent a major target in the defence of the host against the pathogen.

This work, conducted by research teams from the Laboratoire Pharmacochimie et Pharmacologie pour le Développement (Université Toulouse III -- Paul Sabatier/IRD) and the Institut de Pharmacologie et de Biologie Structurale (CNRS/Université Toulouse III -- Paul Sabatier), was initially carried out on mice then on human cells. It shows that dectin-1 and mannose receptors have an inhibiting effect on the parasite. In fact, they trigger the production of oxygenated free radicals[2] and inflammatory mediators, thereby helping to eliminate the parasite. The researchers also highlighted the opposite role of the DC-SIGN receptor, which participates in the phagocytosis of Leishmania and favors its proliferation by inhibiting macrophage microbicidal activity.

Confirmed in humans, these results also show for the first time that C-type lectins control the balance between pro-inflammatory and anti-inflammatory lipid mediators, contributing to the orientation of the anti-parasitic defence.

This discovery represents a breakthrough in infectious diseases and could pave the way for the development of new medicines.

[1] A macrophage is a cell of the immune system, located in tissues that can be subject to infection or an accumulation of debris that needs to be eliminated (liver, lungs, lymphatic ganglions, spleen, etc.), and which has in particular a phagocytosis function, in other words the ability to ingest and destroy parasites, bacteria, yeasts, cell debris, etc.

2 Oxygenated free radicals are chemical species produced by macrophages that have the property of destroying pathogens.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. Lefèvre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D, Authier H, Duval C, Dardenne C, Bernad J, Lemesre JL, Auwerx J, Neyrolles O, Pipy B, & Coste A, ,. Divergent roles for C-type lectin receptors in the modulation of host cell response to Leishmania infantum. Immunity, 16 May 2013

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Resistance to visceral Leishmaniasis: New mechanisms involved." ScienceDaily. ScienceDaily, 16 May 2013. <www.sciencedaily.com/releases/2013/05/130516063850.htm>.
CNRS (Délégation Paris Michel-Ange). (2013, May 16). Resistance to visceral Leishmaniasis: New mechanisms involved. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2013/05/130516063850.htm
CNRS (Délégation Paris Michel-Ange). "Resistance to visceral Leishmaniasis: New mechanisms involved." ScienceDaily. www.sciencedaily.com/releases/2013/05/130516063850.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) — Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) — California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) — Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins